Teva Reinforces Leadership Position in CNS with Acquisition of Auspex

News   Apr 02, 2015

 
Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
 
 
 

RELATED ARTICLES

Survival Rates Double for Patients with Melanoma Brain Metastases Receiving Immunotherapy

News

Checkpoint blockade immunotherapies significantly improve the survival of patients with melanoma brain metastases, according to a new study.

READ MORE

Altitude Sickness Drug Could Help Patients with Aggressive Brain Cancer

News

A drug used to treat altitude sickness – as well as glaucoma, epilepsy, heart failure and seizures – may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma.

READ MORE

Antibody Drug May Be Effective Against Broader Class of Brain Cancers

News

A new study explains why a particular mutation in the epidermal growth factor receptor (EGFR) results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer glioblastoma multiforme (GBM).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy